ACA
ETON icon

Anchor Capital Advisors’s Eton Pharmaceutcials ETON Stock Holding History

Anchor Capital Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
40,619
-239
-0.6% -$7.01K 0.04% 155
2026
Q1 		$1.01M Buy
40,858
+190
+0.5% +$3.32K 0.03% 163
2025
Q4 		$688K Buy
40,668
+3,890
+11% +$68.5K 0.02% 196
2025
Q3 		$799K Sell
36,778
-50,883
-58% -$844K 0.02% 187
2025
Q2 		$1.25M Buy
87,661
+27,482
+46% +$434K 0.04% 160
2025
Q1 		$781K Sell
60,179
-253
-0.4% -$3.82K 0.02% 184
2024
Q4 		$805K Buy
+60,432
New +$613K 0.02% 189

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Anchor Capital Advisors's ETON Position: Q2 2026 in Review

Anchor Capital Advisors reduced its Eton Pharmaceutcials (ETON) stake by 0.58% in Q2 2026, selling an estimated $7.01K and leaving 40,619 shares worth $1.47M. The position accounts for 0.04% of the portfolio, ranked #155.

Anchor Capital Advisors first reported a position in ETON in Q4 2024 and has held it in 7 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Anchor Capital Advisors held 40,619 shares of Eton Pharmaceutcials worth $1.47M as of Q2 2026.
  • Anchor Capital Advisors sold 239 Eton Pharmaceutcials shares in Q2 2026, an estimated $7.01K.
  • Eton Pharmaceutcials made up 0.04% of Anchor Capital Advisors's portfolio in Q2 2026, its #155 holding.
  • Anchor Capital Advisors first reported a position in Eton Pharmaceutcials in Q4 2024 and has held it in 7 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Anchor Capital Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.